MPR

SimpleScreen CRC Blood-Based Screening Test Receives FDA Approval

Freenome's newly approved blood test offers clinicians an alternative screening option for average-risk adults aged 45 and ...
MPR

Simtriyo Gains FDA Approval as First NDSRI CNS Stimulant for ADHD

Supported by four phase 3 clinical trials, Simtriyo offers a novel triple-reuptake inhibition mechanism for managing core ADHD symptoms across pediatric and adult populations.
MPR

More Than 85 Million US Adults Now Eligible for Statins Under New Guidelines

HealthDay News — The 2026 American Heart Association/American College of Cardiology/multisociety guideline on the management of dyslipidemia has increased the US population recommended for primary ...
MPR

FDA Advisers Dismiss Safety Warnings, Back 4 Peptide Treatments

The votes are nonbinding, but they amount to a rebuke of the FDA’s own scientists who said the drugs have not been studied enough to know whether they are safe or effective.
MPR

Global Morbidity Gap Increased 21.9% From 1990 to 2023

Researchers found that the global morbidity gap increased from 8.8 to 10.7 years from 1990 to 2023, a 21.9% increase. HealthDay News — The global morbidity gap increased from 1990 to 2023, according ...
MPR

Emergency Presentation of Cancer Common in Older Adults

Emergency presentation (EP) for cancer diagnosis is common among older US adults and predicts persistently elevated mortality, according to a study published online July 14 in the Journal of the ...